Position in LLY
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$17,007,918
+$4,023,525 QoQ
Shares Held
14,180
+0.4% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
1.35%
of 13F equity value
Holder Rank
#972
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Jacobi Capital Management LLC holds $62,099,576 across 14 Drug Manufacturers - General names. LLY ranks #1 (27.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
14,180 | $17,007,918 | |
| 2 | MRK |
Merck & Co., Inc.
|
71,539 | $9,192,761 | |
| 3 | JNJ |
Johnson & Johnson
|
33,028 | $8,388,121 | |
| 4 | ABBV |
AbbVie Inc.
|
32,674 | $8,222,085 | |
| 5 | AMGN |
Amgen Inc
|
12,553 | $4,545,692 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
64,849 | $3,736,599 | |
| 7 | PFE |
Pfizer Inc
|
133,653 | $3,218,364 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
23,324 | $2,946,754 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $17,007,918 | 14,180 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $12,984,393 | 14,117 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $15,164,810 | 14,111 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $11,113,858 | 14,566 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $10,757,514 | 13,800 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $11,372,780 | 13,770 | Shares | Sole | 2025-05-27 | |
| 2024-12-31 | $10,601,104 | 13,732 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $11,187,650 | 12,628 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $11,477,502 | 12,677 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $9,904,986 | 12,732 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $8,665,688 | 14,866 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $8,805,709 | 16,394 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $7,140,689 | 15,226 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $5,395,471 | 15,711 | Shares | Sole | 2023-05-05 | |
| 2022-12-31 | $5,537,354 | 15,136 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $4,960,189 | 15,340 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $5,173,089 | 15,955 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $4,597,097 | 16,053 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $4,445,208 | 16,093 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $3,673,232 | 15,898 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $3,794,195 | 16,531 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $3,053,199 | 16,343 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $2,676,789 | 15,854 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $2,322,285 | 15,689 | Shares | Sole | 2020-10-30 | |
| 2020-06-30 | $2,554,476 | 15,559 | Shares | Sole | 2020-08-04 | |
| 2020-03-31 | $2,194,550 | 15,820 | Shares | Sole | 2020-04-24 | |
| No filing history on record for this holder in this stock. | ||||||